MBI-LCBI and CLABSI: more than scrubbing the line.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Microbiota dynamics in a randomized trial of gut decontamination during allogeneic hematopoietic cell transplantation.JCI insight · 2022
   Trial
2. Epidemiology of hospital-acquired bloodstream infections in haemato-oncology patients in Geneva, Switzerland.Infection · 2025
   Article
3. Mucosal barrier injury as an independent risk factor for laboratory-confirmed bloodstream infection in patients with hematological malignancies: a real-world study.European journal of medical research · 2025
   Article
4. Infection prevention requirements for the medical care of immunosuppressed patients: recommendations of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute.GMS hygiene and infection control · 2022
   Article
5. Implementation of a central-line bundle: a qualitative study of three clinical units.Implementation science communications · 2021
   Article
6. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2021
   Article
7. The microbiome in pediatric oncology.Cancer · 2020
   Review
8. Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant.JAMA network open · 2020
   Article
9. Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients.Pediatric blood & cancer · 2019
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as